so what? A poster.The FDA decision is the only thing that matters.I have seen them say No in the face of clear evidence.
This is short covering until the shorts can get back in tomorrow
Think it has anything t do with the fact that Insmed will be required to do another trial?
It failed the primary endpoint. The "cures" are SKEWED data.
Too real for this board aswpe, but I give 2017+ a 40% chance.
60% NTM by late 2015.
US . CF 50% any chance
You got it but that is with positive results.Most are now betting the news is weak results. You may want to try a covered call around 17.70 and Sell Calls 4/19/14 strike 17.50 around $5.10
When Insmed "shelved" iPlex it was because the drug failed to produce results that would advance the drug to commercialization.
To report that the reason the drug was shelved was because they ran out of the drug!! or better yet talk to some at Insmed asI have.
Social Security Medicare Unemployment benefits and you think Socialism doesn't work? You are an idiot.The US is the only country without socialized medicine in the modern world and the insurance companies that are producing jerks like you love it.Carry on
Shire does not plan to manufacture iplex. Shire is testing iplex only to find an alternative for ROP
Insmed has no mention of iplex on its site or in their investor presentations.You are a liar.No one plans iPlex production. Insmed has told you repeatedly that they have no interest in iPlex.This has to be one idiot.Insmed has Arikace for CF and maybe NTM